NeoDoppler: New Ultrasound Technology for Continuous Monitoring of Cerebral Circulation Pilot

Non-invasive tools for monitoring of course of disease are important and necessary in the treatment of pre-term/premature infants and sick neonates. For many years, the ultrasound group in Trondheim has been at the forefront in the development of new ultrasound technology for the diagnosis and monitoring of disease. Several methods previously developed in this research group are today widely used in hospitals around the world. In this project the investigators aim to test a new ultrasound technology that allows continuous monitoring of cerebral blood flow in sick neonates and pre-term children. This technology was CE-certified in October 2022, and in this project the investigators will test the CE-certified version with the newest available approved software.

NCT Number	NCT06646250
Lead Sponsor	St. Olavs Hospital Collaborators: Norwegian University of Science and Technology
Conditions	Preterm, Patent Ductus Arteriosus, Sepsis, Asphyxia, Stroke, Pulmonary Hypertension, Congenital Heart Disease
Enrollment	180 participants
Start Date	2024-10-20
Primary Completion	2028-12-31 (estimated)
Study Completion	2029-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-23